I have a two questions for you...

• What medications do we have that were developed specifically for Migrane and headache prevention?
• Which medications were developed specifically for Migrane and headache prevention?
  

OK. You got me. They're trick questions.

We have NO medications that were specifically developed for Migraqine and headache prevention.

   None...

      ...Zero...

         ...zip...

            ...nada...

               ...zilch....

   A big, fat 0.

Surprised? Yeah, it's pretty pathetic.

Now, please take a good, hard look at these statistics...

Migraine and other headache disorders are the most prevalent neurological disorders. This year...

• more than 25% of middle-aged American women will have a Migraine attack.
• 25% of American families will have a member with a Migraine attack.
• 19% of Iraq war veterans will have a Migraine attack.
• 4% of Americans will have chronic daily headache.

Migraine disease results in...

• attacks that can be as disabling as quadriplegia or active psychosis.
• more lost years of healthy life in the us than epilepsy, multiple sclerosis, and ovarian cancer combined.
• an increaqsed risk of cardiovascular diseae leading to at least 1,500 additional deaths in the U.S. annually.

BUT, we have NO medications developed for prevention, and our choices of Migraine abortives are limited. If you have heart issues or history of stroke, most doctors feel it's too dangerous to take triptans or any of the ergotamines, so the only abortive option left is Midrin.

Does this frustrate you? ... make you angry?

Want to do something about it? Here's your chance, and it takes less than 10 minutes of your time. Please read the action alert below, then click the link to email your delegate in the House of Representatives:

Dear AHDA advocates -

The moment has arrived for you to contact your members of the US House of Representatives to take action for increasing National Institutes of Health (NIH) research on headache disorders.

Please go to the AHDA website as soon as possible to send strong but focused emails to your members of the House with just a few clicks.

Publicly funded research is the key to fundamental discoveries that accelerate drug development and expand the field of headache medicine. However, the NIH has never provided adequate funding for research on headache disorders. Currently, NIH expenditures for headache research are less than $13M annually, comprising less than 0.05% of the NIH budget. Meanwhile, headache disorders cost more than $31B in the US annually, including 9% of lost labor productivity, and result in more lost years of healthy life every year than epilepsy, multiple sclerosis, and ovarian cancer combined. As a consequence of insufficient research, only two innovative drugs have received FDA approval for migraine treatment in the past fifty years.